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Background: Coagulopathy often develops in patients with serious trauma and is correlated with the clinical
outcome. The contribution of platelet activity and endothelial dysfunction to trauma-induced coagulopathy remain
to be defined. The purpose of this study was to investigate the time courses of soluble P-selectin (sPsel, an index of
platelet activation) and von Willebrand factor (VWF, an index of endothelial dysfunction) in trauma patients and
elucidate their relationship to coagulation parameter levels, the presence of coagulopathy, and patient outcome.
Methods: This prospective observational study, which took place in a university hospital intensive care unit (ICU),
included 82 severely injured trauma patients. The sPsel, VWF antigen, protein C, and factor VII levels were measured
and routine coagulation tests were performed upon admission to ICU and daily within the first week. The 30-day
mortality rate was also determined.
Results: Thirty-seven (45.1%) patients developed coagulopathy upon admission to the ICU, and the 30-day
mortality rate was 20.7% (n = 17). Both the admission sPsel and VWF levels were lower in patients with
coagulopathy than in those without (p < 0.05) and were significantly correlated with the protein C and factor VII
levels, respectively (all p < 0.05). The VWF levels were lower during the first 3 days and higher on day 7 after
admission in nonsurvivors than in survivors (all p < 0.05). No significant differences in sPsel levels were found
between nonsurvivors and survivors on each day during the first week.
Conclusion: In severely injured trauma patients in the ICU, lower levels of sPsel and VWF on admission were
associated with the presence of coagulopathy and might not predict a better outcome. An increase in the VWF
level at the end of the first week after admission to ICU was associated with increased 30-day mortality.
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When death due to exsanguination does not immedi-
ately occur in trauma patients, bleeding and shock in-
crease the risk of multiple organ failure and late mortality.
Much attention has been given to coagulopathy because it
is an independent predictor of mortality. The proposed
mechanism of trauma-induced coagulopathy (TIC) is that
shock and tissue injury lead to systemic anticoagulation
by widespread endothelial damage and activation of
protein C (PC) [1]. Thrombin generation, PC activation,
and hyperfibrinolysis are all associated with endothelial* Correspondence: indicator2001@sina.com
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reproduction in any medium, provided the orglycocalyx degradation [2]. Meanwhile, TIC and the com-
bined effects of shock and hypothermia would theoretic-
ally result in platelet dysfunction through disruption of
activation and adhesion pathways [3]. To date, how-
ever, the contribution of platelet activity and endothelial
damage/dysfunction to TIC remain to be defined; doing
so may offer novel therapeutic targets [4].
Soluble P-selectin (sPsel) and von Willebrand factor
(VWF) have been described as plasma markers of platelet
activation and endothelial damage/dysfunction, respectively
[5,6]. Characterizing the evolution of sPsel and VWF levels
in trauma patients may help to understand the roles of
platelet activation and endothelial dysfunction in trauma
and TIC. Our hypothesis was that in severe trauma patients,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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TIC and that changes in these levels in the early stage
may predict outcomes. Therefore, the aim of our study
was to investigate whether correlations exist among levels
of sPsel, VWF, and coagulation parameters; the presence
of coagulopathy; and 30-day mortality among trauma
patients.
Methods
All consecutive trauma patients admitted to the inten-
sive care unit (ICU) between May and September 2012
and who had a >48-h estimated length of stay in the
ICU were included in this study. Exclusion criteria were
as follows: <18 y of age, pregnant, or currently undergo-
ing anticoagulation or antiplatelet therapy.
This study was approved by the Ethics Committee of
Tongji Hospital (Wuhan, China), and written informed
consent was obtained from all patients or their family
members.
On admission to the emergency room, patients were
initially evaluated, were resuscitated (with crystalloids),
and then underwent emergency surgery when necessary.
Only the patients transferred to the ICU within 24 h of
the injury were included in the study. Blood samples
were collected daily after admission to ICU for 1 week;
the first sampling was completed as early as possible fol-
lowing admission. The Injury Severity Score (ISS) was
also obtained on admission to the ICU.
In the central clinical laboratory of Tongji Hospital,
the blood samples were collected into citrate vacuum
tubes and centrifuged at 2000 × g for 10 min. Platelet-
poor plasma was obtained for immediate analysis or
storage at −70°C within 1 month. sPsel concentrations
were determined by commercially available ELISA kits
(R&D Systems, Inc., USA). VWF antigen, coagulation
factor VII (FVII), and PC concentrations were deter-
mined and routine coagulation tests (prothrombin time,
activated partial thromboplastin time, and fibrinogen)
were performed using the STA-R automated coagulation
analyzer and commercially available reagents (Diagnostica
Stago, France). Data on hemoglobin (Sysmex 2100;
Sysmex Corp., Japan) and blood glucose (Modular DPP;
Roche Corp., USA) on the first day were collected from
the laboratory information system.
TIC was defined as a prothrombin ratio (PTR) of >1.2
within 1 day after admission according to a recent epi-
demiological study of >5000 patients [7].
Statistical analysis
The Kolmogorov–Smirnov test was used to verify the
normality of distribution of continuous variables. Nor-
mally distributed quantitative variable were compared
between patients with and without coagulopathy and be-
tween survivors and nonsurvivors by Student’s t test anddescribed as mean ± standard deviation. Non-normally
distributed quantitative variables were compared by the
Mann–Whitney U test and described as median values
and interquartile ranges; qualitative variables were com-
pared by the chi-square test and described in figures and
as percentages. Pearson’s or Spearman’s correlation coef-
ficients were calculated to determine correlations be-
tween sPsel/VWF levels and other variables. A p value
of <0.05 was considered to be statistically significant.
Data were analyzed using SPSS 13.0 for Windows (SPSS
Inc., Chicago, IL).
Results
A total of 82 patients (54 male, 28 female; mean age,
45.3 years) were enrolled in this study. No antithrombin,
recombinant activated human PC, or recombinant FVII
concentrations were given for the included patients.
None of the patients had received blood product trans-
fusions until arrival at the hospital. Thirty-seven (45.1%)
patients developed coagulopathy upon admission to the
ICU or during the first day. The 30-day mortality rate
was 20.7% (n = 17); 13 patients died of multiple organ
dysfunction syndrome, 3 died of respiratory dysfunction,
and 1 died of acute cerebral hemorrhage. Table 1 delin-
eates the demographics, clinical characteristics, and admin-
istration of blood components on the first day stratified
into patients with and without coagulopathy.
Correlations between levels of sPsel/VWF and levels of
coagulation parameters (PC and FVII) upon admission
to the ICU are presented in Table 2; significant associa-
tions were noted (Figures 1 and 2).
The evolution of sPsel and VWF levels during the first
week after admission to the ICU, stratified by outcome,
is presented in Figure 1. The sPsel and VWF levels were
mostly above the upper limit of normal throughout the
first week. The admission sPsel and VWF levels were
above the upper limit of normal in 63.4% (n = 52) and
85.4% (n = 70) of patients, respectively. No significant
differences were found in sPsel levels on each day be-
tween survivors and nonsurvivors (Figure 3a). VWF
levels were lower during the first 3 days and higher on
day 7 in nonsurvivors than in survivors (all p < 0.05)
(Figure 3b).
Discussion
The main finding of this study was that both the admission
sPsel and VWF levels were lower in patients with than
without TIC and were significantly correlated with the co-
agulation parameter levels. Early VWF levels among trauma
patients in the ICU were lower in nonsurvivors than in sur-
vivors; however, at the end of the first week, VWF levels be-
came higher in nonsurvivors than in survivors.
In the current study, TIC was defined as an admission
PTR of >1.2 according to Frith’s epidemiological study
Table 1 Patients stratified by presence of coagulopathy
Total Coagulopathy Non-coagulopathy P value
(n = 82) (n = 37) (n = 45)
Age (y) 45.3 ± 8.2 47.2 ± 7.1 41.5 ± 5.9 0.419
Male, n (%) 54 (65.9%) 26 (70.3%) 28 (62.2%) 0.490
Blunt trauma 79 (96.3%) 35 (94.6%) 44 (97.8%) 0.550
Type of trauma
Cerebral 18 8 10
Extremities 2 0 2
Abdominal 6 1 5
Thoracic 10 3 7
Multi trauma 43 24 19
Other 3 1 2
ISS 27.6 ± 2.2 33.8 ± 3.5 23.3 ± 1.8 0.003
30-day mortality, n (%) 17 (20.7%) 13 (35.1%) 4 (8.9%) 0.004
Laboratory analyses on admission
sPsel (NR: 20–44 ng/mL) 54.8 ± 22.6 49.4 ± 26.0 59.5 ± 18.2 0.044
VWF (NR: 66–176%) 224.1 (198.3-245.1) 205.8 (135.5-231.1) 244.2 (199.2-247.2) 0.014
PTR (NR: 0.88-1.12) 1.18 (1.07-1.56) 1.68 (1.41-1.74) 1.08 (1.05-1.13) <0.001
Protein C (NR: 70–130%) 76.7 ± 38.8 48.0 ± 19.1 101.5 ± 34.2 <0.001
Factor VII (NR: 55–170%) 74.4 ± 37.0 46.0 ± 24.2 98.9 ± 27.5 <0.001
Hemoglobin (NR: 110-160 g/L) 101.1 ± 29.9 90.3 ± 29.4 109.8 ± 27.6 0.022
Glucose 8.39 ± 2.78 8.86 ± 3.15 8.09 ± 2.38 0.411
(NR: 4.11-6.05 mmol/L)
Transfusions in units for the first day
PLTC 1.5 (1.0-2.0) 1.5 (1.0-2.0) 0
(n = 5) (n = 5)
FFP 3.5 (2.5-7.0) 4.0 (3.0-7.5) 2 and 4 units 0.230
(n = 9) (n = 7) (n = 2)
PRBC 2.5 (1.5-4.0) 2 and 2 units 2.5 (1–4.5) 0.315
(n = 13) (n = 2) (n = 11)
Frequencies are given as count with percentage and were compared by the chi-square test. Transfusions (units) and admission VWF and PTR levels are given as
medians (interquartile range) and were compared by the Mann–Whitney U test. Levels of other parameters, age, and ISS are given as means ± standard deviations
and were compared by Student’s t test. ISS Injury Severity Score, NR normal range, PLTC platelet concentrates, FFP fresh frozen plasma, PRBC packed red
blood cells.
Table 2 Correlations between levels of sPsel/VWF
and coagulation parameters upon admission








Admission PC 0.401 <0.001 0.245 0.026
Admission FVII 0.456 <0.001 0.253 0.022
sPsel soluble P-selectin, VWF von Willebrand factor, PC protein C,
FVII coagulation factor VII.
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increase in mortality and blood product requirements. In
addition, the authors were able to demonstrate that the
often-cited coagulopathy threshold of PTR/INR > 1.5 fails
to detect 16% of patients with poor outcomes. Using a
threshold of PTR > 1.2, 45.1% of the included patients
were defined as having TIC in our study and were as-
sociated with a higher ISS and 30-day mortality rate.
Meanwhile, we selected PC and FVII as the markers
of coagulation; these parameters have been described
as sensitive indices for coagulopathy and were associ-
ated with the outcome of trauma patients [8,9].
VWF is synthesized in endothelial cells and megakar-
















































Figure 1 Correlations between admission levels of sPsel and
coagulation parameters. Correlations between admission levels of
sPsel and FVII (a) and PC (b). Abbreviations: sPsel, soluble P-selectin;















































Figure 2 Correlations between admission levels of VWF and
coagulation parameters. Correlations between admission levels of
VWF and FVII (a) and PC (b). Abbreviations: VWF, von Willebrand
factor; FVII, coagulation factor VII; PC, protein C.
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Activated platelets may occasionally contribute to the
circulating pool of VWF in patients with thrombotic dis-
orders, but platelet VWF after release from α granules
tends to remain bound to the platelet surface. Thus, we
may assume that the majority of plasma VWF comes
from endothelial cells and that an increase in plasma
VWF levels can indicate endothelial activation/damage.
P-selectin is an adhesion molecule present in platelets; it
is expressed on the platelet surface upon activation as
well as on the endothelium in the presence of an athero-
sclerotic plaque. However, sPsel in the plasma is thought
to arise predominantly from platelets with a minimal
contribution from endothelial cells, suggesting that sPsel
is likely to reflect platelet activation [11,12]. Increased
levels of sPsel/VWF have been observed in patients with
stroke, coronary artery disease, acute myocardial in-
farction, and deep vein thrombosis [13-19]. Endothelial
damage and platelet dysfunction also seem to be present
in patients with severe trauma and TIC, but the mecha-
nisms by which this damage and dysfunction develop are
still largely unknown. Meanwhile, the evolution of sPsel
and VWF levels following severe trauma has been poorly
described. In our study, the sPsel and VWF levels in
trauma patients during the first week after entering theICU were generally above the normal reference range re-
gardless of outcome, which suggests persistent activation
of endothelial cells and platelets in these trauma patients.
In our study, the admission VWF levels in patients
with coagulopathy and in nonsurvivors were lower than
those in patients without coagulopathy and survivors.
The admission VWF levels were also correlated with the
admission PC/FVII levels, implicating that early low
VWF levels might be mainly attributed to coagulopathy
and predict a poor outcome. It is known that after ac-
tivation by thrombin (mediated by protease-activated
receptor), endothelial cells release VWF in approximately
30 min [20]; however, in TIC, thrombin generation is im-
paired and/or diluted [1]. This causal relationship may ex-
plain the lower admission VWF levels in patients with
than without coagulopathy. Our VWF results were close
to those of a previous study by Ostrowski et al. [21] on
biomarker profiles in acute TIC, but conflicted with those
of a study by Oliveira et al. [22] in which VWF levels of
patients with severe traumatic brain injury were higher in
nonsurvivors than in survivors upon admission, at 24 h,
and at 7 days. Although the morbidity of coagulopathy in
Oliveira’s study is unknown, we infer that the inconsistent
results of the two studies may be partly attributed to dif-


















Figure 3 Evolution of sPsel and VWF levels during the first week after admission according to outcome. (a) Evolution of sPsel levels
(ng/ml) during the first week after admission according to outcome. The dashed line represents the upper limit of normal for sPsel levels
(44 ng/ml). No significant differences were found in sPsel levels on each day between survivors and nonsurvivors (by Student’s t test or the
Mann–Whitney U test). (b) Evolution of VWF levels (%) during the first week after admission according to outcome. The dashed line represents
the upper limit of normal for VWF levels (176.0%). *p < 0.05 compared with survivors (Mann–Whitney U test).
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nonsurvivors peaked on day 7 and were higher than
those in survivors. Similarly, the VWF levels of patients
with traumatic brain injury in two previous studies [22,23]
peaked on day 7 and within the second week after enter-
ing the ICU. These findings suggest that observing
changes in VWF levels may be helpful in predicting the
mortality of trauma patients in the ICU.
Platelet dysfunction after trauma has been character-
ized in some recent studies [24,25]. Our study also foundthat although the sPsel levels of trauma patients during the
first week were generally above the normal reference range,
the admission sPsel levels in patients with coagulopathy
were lower than the levels in patients without coagulopathy;
they were also correlated with the admission PC/FVII
levels. However, no significant differences in the sPsel levels
between survivors and nonsurvivors were found during the
first week. This may be attributed to the dual nature of se-
vere injury, which promotes both platelet activation and
coagulopathy that impedes platelet activation. Our data
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essential for correction of TIC in numerous clinical trials
[26-29]. However, transfusion of normally functioning
platelets may be associated with additional benefits such as
restoration of the endothelium and modulation of infective
and inflammatory sequelae [4].
This study has several limitations. Since initial samples
were collected after admission to the ICU, the impacts
of emergency treatments prior to admission on coagula-
tion markers had not been evaluated, for example, patients
with traumatic brain injury in our study received mannitol
to reduce acutely raised intracranial pressure until more
definitive treatment can be applied, limited literatures have
reported the functions of mannitol on inhibiting platelet
activation and increasing vasopermeability of endothelial
cells [30,31], its possible effects on sPsel/VWF levels might
have interfered our results. Second, as an observational
study, it did not allow for independent estimation of the
cause-and-effect relationship between sPsel/VWF levels
and outcome. Third, because of the limited number of pa-
tients and amount of clinical data included, a more de-
tailed classification and analysis of the enrolled patients
(e.g., according to the presence of sepsis or organ fail-
ure) could not be performed. Fourth, conditions pos-
sibly affecting sPsel and VWF levels in the enrolled
patients, such as von Willebrand disease or congenital
platelet function defects, were not excluded.
In conclusion, our study revealed that sPsel and VWF
levels in trauma patients are generally above the normal
reference range for at least 1 week. The admission levels
of sPsel and VWF are greatly influenced by the presence
of coagulopathy such that the relatively lower levels of
these parameters in trauma patients often do not predict
less platelet/endothelial dysfunction or a better outcome.
Moreover, restoration of endothelial function seems to
be a very important factor in improving the prognosis of
trauma patients. Further prospective studies with larger
sample sizes are needed to confirm these conclusions.
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